Rocket Pharmaceuticals, Inc. (RCKT)

USD 11.74

(-1.51%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 566.34 Million 551.8 Million 497.02 Million 590.82 Million 372.12 Million 251.31 Million
Total Current Assets 378.22 Million 364.06 Million 392.05 Million 487.34 Million 307.75 Million 209.08 Million
Cash And Short Term Investments 373.17 Million 356.39 Million 388.74 Million 482.71 Million 304.11 Million 205.73 Million
Cash and Cash Equivalents 55.9 Million 140.51 Million 232.69 Million 297.09 Million 185.38 Million 111.35 Million
Short Term Investments 317.27 Million 215.87 Million 156.04 Million 185.62 Million 118.73 Million 94.37 Million
Net Receivables - - - - - -
Inventory - - - - - -
Other Current Assets 5.04 Million 7.66 Million 3.31 Million 4.62 Million 3.63 Million 3.35 Million
Total Non-Current Assets 188.11 Million 187.74 Million 104.96 Million 103.47 Million 64.36 Million 42.22 Million
Net PPE 87.59 Million 77.64 Million 72.34 Million 70.64 Million 31.34 Million 2.02 Million
Good Will And Intangible Assets 64.3 Million 64.87 Million 30.81 Million 30.81 Million 31.04 Million 30.81 Million
Good Will 39.15 Million 39.15 Million 30.81 Million 30.81 Million 30.81 Million 30.81 Million
Intangible Assets 25.15 Million 25.72 Million - - 226 Thousand -
Long-Term Investments 34.32 Million 43.27 Million 1.34 Million 1.56 Million 1.52 Million 7.4 Million
Tax Assets 533 Thousand - -1.34 Million -1.56 Million -1.52 Million 545 Thousand
Other Non Current Assets 1.37 Million 1.94 Million 1.79 Million 2.02 Million 1.98 Million 1.43 Million
Other Assets - - 0.00 0.00 0.00 -
Total Liabilities 73.76 Million 62.12 Million 42.29 Million 87.3 Million 64.82 Million 57.27 Million
Total Current Liabilities 48.5 Million 39.16 Million 22.16 Million 32.61 Million 18.3 Million 15.37 Million
Account Payables 1772.00 36.66 Million 482.00 835.00 340.00 589.00
Tax Payables - - - - - -
Short Term Debt 2.71 Million 2.5 Million 2.55 Million 7.14 Million 957 Thousand -589.00
Deferred Revenue -1772.00 -36.66 Million -482.00 590 Thousand 562 Thousand 534 Thousand
Other Current Liabilities 45.78 Million 36.66 Million 19.61 Million 24.88 Million 16.78 Million 14.83 Million
Total Non Current Liabilities 25.26 Million 22.95 Million 20.12 Million 54.68 Million 46.51 Million 41.9 Million
Long-Term Debt 22.32 Million 20.35 Million 20.04 Million 54.55 Million 46.49 Million 41.44 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.93 Million 2.59 Million 80 Thousand 136 Thousand 23 Thousand 457 Thousand
Other Liabilities - - - - - -
Total Equity 492.57 Million 489.68 Million 454.72 Million 503.51 Million 307.29 Million 194.03 Million
Stock Holders Equity 492.57 Million 489.68 Million 454.72 Million 503.51 Million 307.29 Million 194.03 Million
Common Stock 903 Thousand 791 Thousand 645 Thousand 610 Thousand 548 Thousand 452 Thousand
Retained Earnings -959.37 Million -713.77 Million -491.91 Million -322.84 Million -183.14 Million -105.87 Million
Accumulated other comprehensive income 319 Thousand -357 Thousand -161 Thousand -42 Thousand 20 Thousand -127 Thousand
Common Stock Equity 492.57 Million 489.68 Million 454.72 Million 503.51 Million 307.29 Million 194.03 Million
Capital Lease Obligation 25.04 Million 22.86 Million 22.6 Million 21.75 Million 2.4 Million -
Total Investments 34.32 Million 259.15 Million 156.04 Million 185.62 Million 118.73 Million 101.77 Million
Total Debt 25.04 Million 22.86 Million 22.6 Million 61.69 Million 47.44 Million 41.44 Million
Net Debt -30.86 Million -117.65 Million -210.09 Million -235.4 Million -137.93 Million -69.9 Million

Balance Sheet Charts